Waqoo Inc. (TYO:4937)
Japan · Delayed Price · Currency is JPY 2,284.00
+30.00 (1.33%)
Aug 27, 2026, 3:30 PM JST
Waqoo Financials Overview
Financials in millions JPY. Fiscal year is October - September.
Millions JPY. Fiscal year is Oct - Sep.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2017 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '17 Sep 30, 2017 |
Revenue Revenue Growth | 2,683 | 1,960 | 1,943 | 1,726 | 2,731 | 1,566 |
Revenue Growth | 46.21% | 0.88% | 12.57% | -36.80% | 74.37% | - |
Gross Profit Gross Profit Growth | 1,997 | 1,559 | 1,549 | 1,311 | 1,929 | 1,080 |
Operating Income Operating Income Growth | 600 | 151 | 59 | 278 | -40 | 7.52 |
Net Income Net Income Growth | 497 | 44 | -17 | 28 | -57 | 34.88 |
Earnings Per Share EPS Growth | 140.31 | 12.24 | -4.91 | 9.31 | -18.98 | - |
EPS Growth | 1479.78% | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
D2C Business D2C Business Growth | 952.59 | 1,316 | 1,561 | 2,531 |
Unallocated Adjustment Unallocated Adjustment Growth | -1.49 | -1.67 | -1.23 | - |
Medical Support Segment Medical Support Segment Growth | 1,001 | 628.67 | 166.5 | 200.01 |
Other Other Growth | 9.3 | - | - | - |
Total Total Growth | 1,961 | 1,943 | 1,726 | 2,731 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2017 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '17 Sep 30, 2017 |
Cash & Investments Cash & Investments Growth | 1,579 | 1,302 | 1,505 | 1,305 | 906 | 351.06 |
Total Debt Total Debt Growth | 568 | 730 | 783 | 635 | 644 | 148 |
Net Cash (Debt) Net Cash Growth | 1,011 | 572 | 722 | 670 | 262 | 203.06 |
Net Cash Growth | 122.69% | -20.78% | 7.76% | 155.72% | 29.03% | - |
Net Cash Per Share Net Cash Per Share Growth | 285.50 | 159.67 | 208.45 | 220.08 | 87.26 | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2017 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '17 Sep 30, 2017 |
Operating Cash Flow Operating Cash Flow Growth | - | 136 | 48 | 455 | 168 | - |
Capital Expenditures CapEx Growth | - | -193 | -79 | - | - | - |
Free Cash Flow Free Cash Flow Growth | - | -57 | -31 | 455 | 168 | - |
Free Cash Flow Growth | - | - | - | 170.83% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2017 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '17 Sep 30, 2017 |
Gross Margin | 74.43% | 79.54% | 79.72% | 75.96% | 70.63% | 68.93% |
Operating Margin | 22.36% | 7.70% | 3.04% | 16.11% | -1.47% | 0.48% |
Pretax Margin | 22.14% | 7.76% | 2.93% | 1.91% | -0.81% | 2.82% |
Profit Margin | 18.52% | 2.25% | -0.88% | 1.62% | -2.09% | 2.23% |
FCF Margin | - | -2.91% | -1.59% | 26.36% | 6.15% | - |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2017 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 27, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '17 Sep 30, 2017 |
PE Ratio | 16.28 | 113.81 | - | 239.73 | - | - |
P/FCF Ratio | 45.72 | - | - | 14.75 | 14.10 | - |
PS Ratio | 3.03 | 2.56 | 2.80 | 3.89 | 0.87 | - |